More on IBX
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $25.98 |
|
|||
| Open | $23.82 | ||||
| 52 Wk High | $0.90 | ||||
| 52 Wk Low | $0.48 | ||||
| Day High | $23.97 | ||||
| Day Low | $22.25 | ||||
| P/E | 105.95 | ||||
| EPS | $0.22 | ||||
| Volume | 905,119 | ||||
- Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
- Imagion Biosystems receives FDA clearance for MagSense breast cancer trial
- Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
- Tradr Launches Leveraged ETFs on AMZN, AAOI, HL and IBM
- Tradr Set to Launch Leveraged ETFs on AMZN, AAOI, HL and IBM
- Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
- Imagion Biosystems submits FDA application for HER2 breast cancer imaging trial
- Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
- Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream
Entities mentioned with IBX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
